Karmi N, Bangma A, Spekhorst LM, van Dullemen HM, et al. Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFalpha therapy in inflammatory bowel disease. PLoS One 2021;16:e0256860.
PMID: 34534227